Status In progress
Process STA pre-2018
ID number 1048

Provisional Schedule

Expected publication 01 August 2018

Project Team

Project lead Jeremy Powell

Email enquiries


Companies sponsors Sanofi
Others Department of Health and Social Care
  NHS England
  Welsh Government
Professional groups British Association of Dermatologists
  British Dermatological Nursing Group
  Royal College of Physicians


Comparator companies Actavis UK (azathioprine) – not participating
  Aspen (azathioprine)
  Dexcel-Pharma Limited (ciclosporin) – not participating
  Novartis Pharmaceuticals (ciclosporin)
  Sandoz (azathioprine) - not participating
  Santen UK (ciclosporin) - not participating
General commentators All Wales Therapeutics and Toxicology Centre
  British National Formulary
  Department of Health, Social Services and Public Safety for Northern Ireland
  Healthcare Improvement Scotland
  Welsh Health Specialised Services Committee
Relevant research groups UK Dermatology Clinical Trials Network


Key events during the development of the guidance:

Date Update
22 June 2018 - 06 July 2018 Final appraisal determination
10 May 2018 Committee meeting: 2
03 April 2018 - 24 April 2018 Appraisal consultation
06 March 2018 Committee meeting: 1
02 October 2017 Invitation to participate
10 August 2017 In progress, In progress
26 July 2017 Referral
20 January 2017 Draft scope documents

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance